WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis

Chih Yang Lin, Huey En Tzeng, Te Mao Li, Hsien Te Chen, Yi Lee, Yi Chen Yang, Shih Wei Wang, Wei Hung Yang, Chih Hsin Tang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Chondrosarcoma is the second most prevalent general primary tumor of bone following osteosarcoma. Chondrosarcoma development may be linked to angiogenesis, which is principally elicited by vascular endothelial growth factor-A (VEGF-A). VEGF-A level has been recognized as a prognostic marker in angiogenesis. WNT1-inducible signaling pathway protein-3 (WISP)-3/CCN6 belongs to the CCN family and is involved in regulating several cellular functions, including cell proliferation, differentiation, and migration. Nevertheless, the effect of WISP-3 on VEGF-A production and angiogenesis in human chondrosarcoma remains largely unknown. This current study shows that WISP-3 promoted VEGF-A production and induced angiogenesis of human endothelial progenitor cells. Moreover, WISP-3-enhanced VEGF-A expression and angiogenesis involved the c-Src and p38 signaling pathways, while miR-452 expression was negatively affected by WISP-3 via the c-Src and p38 pathways. Our results illustrate the clinical significance of WISP-3, VEGF-A and miR-452 in human chondrosarcoma patients. WISP-3 may illustrate a novel therapeutic target in the metastasis and angiogenesis of chondrosarcoma.

Original languageEnglish
Pages (from-to)39571-39581
Number of pages11
JournalOncotarget
Volume8
Issue number24
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Chondrosarcoma
Vascular Endothelial Growth Factor A
Osteosarcoma
Endothelial Progenitor Cells
human WISP3 protein
Inhibition (Psychology)
Cell Movement
Cell Differentiation
Cell Proliferation
Neoplasm Metastasis
Bone and Bones

Keywords

  • Angiogenesis
  • MiR-452
  • VEGF-A
  • WISP-3

ASJC Scopus subject areas

  • Oncology

Cite this

WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis. / Lin, Chih Yang; Tzeng, Huey En; Li, Te Mao; Chen, Hsien Te; Lee, Yi; Yang, Yi Chen; Wang, Shih Wei; Yang, Wei Hung; Tang, Chih Hsin.

In: Oncotarget, Vol. 8, No. 24, 01.01.2017, p. 39571-39581.

Research output: Contribution to journalArticle

Lin, Chih Yang ; Tzeng, Huey En ; Li, Te Mao ; Chen, Hsien Te ; Lee, Yi ; Yang, Yi Chen ; Wang, Shih Wei ; Yang, Wei Hung ; Tang, Chih Hsin. / WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis. In: Oncotarget. 2017 ; Vol. 8, No. 24. pp. 39571-39581.
@article{eb1a7e88c56c44a7a07e6abf3f7abe68,
title = "WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis",
abstract = "Chondrosarcoma is the second most prevalent general primary tumor of bone following osteosarcoma. Chondrosarcoma development may be linked to angiogenesis, which is principally elicited by vascular endothelial growth factor-A (VEGF-A). VEGF-A level has been recognized as a prognostic marker in angiogenesis. WNT1-inducible signaling pathway protein-3 (WISP)-3/CCN6 belongs to the CCN family and is involved in regulating several cellular functions, including cell proliferation, differentiation, and migration. Nevertheless, the effect of WISP-3 on VEGF-A production and angiogenesis in human chondrosarcoma remains largely unknown. This current study shows that WISP-3 promoted VEGF-A production and induced angiogenesis of human endothelial progenitor cells. Moreover, WISP-3-enhanced VEGF-A expression and angiogenesis involved the c-Src and p38 signaling pathways, while miR-452 expression was negatively affected by WISP-3 via the c-Src and p38 pathways. Our results illustrate the clinical significance of WISP-3, VEGF-A and miR-452 in human chondrosarcoma patients. WISP-3 may illustrate a novel therapeutic target in the metastasis and angiogenesis of chondrosarcoma.",
keywords = "Angiogenesis, MiR-452, VEGF-A, WISP-3",
author = "Lin, {Chih Yang} and Tzeng, {Huey En} and Li, {Te Mao} and Chen, {Hsien Te} and Yi Lee and Yang, {Yi Chen} and Wang, {Shih Wei} and Yang, {Wei Hung} and Tang, {Chih Hsin}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.17142",
language = "English",
volume = "8",
pages = "39571--39581",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "24",

}

TY - JOUR

T1 - WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis

AU - Lin, Chih Yang

AU - Tzeng, Huey En

AU - Li, Te Mao

AU - Chen, Hsien Te

AU - Lee, Yi

AU - Yang, Yi Chen

AU - Wang, Shih Wei

AU - Yang, Wei Hung

AU - Tang, Chih Hsin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Chondrosarcoma is the second most prevalent general primary tumor of bone following osteosarcoma. Chondrosarcoma development may be linked to angiogenesis, which is principally elicited by vascular endothelial growth factor-A (VEGF-A). VEGF-A level has been recognized as a prognostic marker in angiogenesis. WNT1-inducible signaling pathway protein-3 (WISP)-3/CCN6 belongs to the CCN family and is involved in regulating several cellular functions, including cell proliferation, differentiation, and migration. Nevertheless, the effect of WISP-3 on VEGF-A production and angiogenesis in human chondrosarcoma remains largely unknown. This current study shows that WISP-3 promoted VEGF-A production and induced angiogenesis of human endothelial progenitor cells. Moreover, WISP-3-enhanced VEGF-A expression and angiogenesis involved the c-Src and p38 signaling pathways, while miR-452 expression was negatively affected by WISP-3 via the c-Src and p38 pathways. Our results illustrate the clinical significance of WISP-3, VEGF-A and miR-452 in human chondrosarcoma patients. WISP-3 may illustrate a novel therapeutic target in the metastasis and angiogenesis of chondrosarcoma.

AB - Chondrosarcoma is the second most prevalent general primary tumor of bone following osteosarcoma. Chondrosarcoma development may be linked to angiogenesis, which is principally elicited by vascular endothelial growth factor-A (VEGF-A). VEGF-A level has been recognized as a prognostic marker in angiogenesis. WNT1-inducible signaling pathway protein-3 (WISP)-3/CCN6 belongs to the CCN family and is involved in regulating several cellular functions, including cell proliferation, differentiation, and migration. Nevertheless, the effect of WISP-3 on VEGF-A production and angiogenesis in human chondrosarcoma remains largely unknown. This current study shows that WISP-3 promoted VEGF-A production and induced angiogenesis of human endothelial progenitor cells. Moreover, WISP-3-enhanced VEGF-A expression and angiogenesis involved the c-Src and p38 signaling pathways, while miR-452 expression was negatively affected by WISP-3 via the c-Src and p38 pathways. Our results illustrate the clinical significance of WISP-3, VEGF-A and miR-452 in human chondrosarcoma patients. WISP-3 may illustrate a novel therapeutic target in the metastasis and angiogenesis of chondrosarcoma.

KW - Angiogenesis

KW - MiR-452

KW - VEGF-A

KW - WISP-3

UR - http://www.scopus.com/inward/record.url?scp=85020690882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020690882&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.17142

DO - 10.18632/oncotarget.17142

M3 - Article

VL - 8

SP - 39571

EP - 39581

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 24

ER -